WILL SOM230 BE EFFECTIVE IN TREATING DUCTAL CARCINOMA IN SITU? A PROOF OF PRINCIPLE CLINICAL TRAIL

$1,036,956FY2010Department of DefenseDOD

New York University, New York NY

Investigators